M.D. or D.O. degree with board certification in Anatomic/Clinical Pathology and Hematopathology subspecialty
Minimum of eight years attending-level, post-fellowship experience in hematopathology
Experience or fellowship training in FISH, cytogenetics, and molecular diagnostics preferred
Ability to travel extensively
Active or eligible for unrestricted Medical License to practice in CA, FL, and NY
Responsibilities
Provide enterprise leadership and oversight for hematopathology services across multiple sites
Drive diagnostic excellence in morphology and flow cytometry reporting
Collaborate with leaders in cytogenetics and molecular pathology for integrated reporting
Manage staffing and policies for hematopathology and workload distribution
Serve as a thought leader in hematopathology internally and externally
Drive innovation in hematopathology and flow cytometry
Support digital transformation initiatives across the enterprise
Facilitate communication and collaboration between medical staff and lab personnel
Benefits
Generous time off and reimbursement for state licensing fees
Equity participation through a long-term incentive program
Annual bonuses based on performance
Sign-on and relocation assistance may be offered
Commitment to professional growth and overall physician well-being
Full Job Description
Description
NeoGenomics is looking for an Enterprise Director of Hematopathology who wants to learn to continue to learn to allow our company to grow. This is an onsite position, preferably in Aliso Viejo, CA, but can be based out of any NeoGenomics site.
Position Summary:
As the Enterprise Director of Hematopathology you will be a strategic medical leader who provides enterprise-level oversight and functional leadership for a dynamic, multi-site hematopathology organization spanning onsite (wet and dry laboratory) and remote settings. You will establish standards for diagnostic excellence, harmonizes diagnostic workflows across sites, ensures exceptional quality, and elevates customer experience while partnering with laboratory operations, Product Development, and commercial teams.
Responsibilities:
Provide enterprise leadership and functional oversight for hematopathology services across all sites
Drives diagnostic excellence across morphology (bone marrow/peripheral blood and lymphoma services) and flow cytometry reporting
Partners with functional leaders in cytogenetics, FISH, and molecular pathology to ensure best-in-class integrated reporting
Serves as the manager of hematopathology leaders from all sites, ensures appropriate staffing across sites, and establishes consistent policies for workload and case assignment
Serves as a hematopathology thought leader internally and externally
Drives innovation in hematopathology and flow cytometry
Supports broader enterprise initiatives in digital transformation
Ensures effective communication and collaboration between medical staff and lab personnel
May provide training throughout the organization, including to new members who are not direct reports or to allied non-medical personnel
Provides ongoing feedback and annual performance evaluations to direct reports
Performs onsite diagnostic interpretation of hematopathology cases, inclusive of morphology, flow cytometry, FISH, cytogenetics, and integrated case reporting
Education, Experience & Qualifications:
M.D. or D.O. degree and board certification in Anatomic and/or Clinical Pathology and subspeciality boards in Hematopathology are required
At least eight years of attending level, post-fellowship experience in hematopathology is required
Experience or fellowship training in FISH, cytogenetics, and/or molecular diagnostic studies is preferable
Ability to travel extensively
Active, or eligibility for, unrestricted Medical License to practice in the states of CA, FL, and NY is required
About NeoGenomics Laboratories
NeoGenomics Laboratories is a medical laboratory that specializes in cancer genetics testing and information services. The company provides testing services to hospitals, pathologists, oncologists, urologists, and other clinicians throughout the United States. NeoGenomics Laboratories was founded in 2001 and is headquartered in Fort Myers, Florida. The company has laboratories in several states, including Florida, Tennessee, and California. NeoGenomics Laboratories is publicly traded on the NASDAQ stock exchange under the ticker symbol NEO.
